• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Pet scans help guide drug to best treat orthopaedic implant bacterial infections

Bioengineer by Bioengineer
December 16, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

FOR IMMEDIATE RELEASE

Staphylococcus aureus microbes

Credit: Courtesy of the U.S. Centers for Disease Control and Prevention

FOR IMMEDIATE RELEASE

Treating bacterial infections associated with orthopaedic implants has often been a case of too little, too late. The traditional therapy has been a combination of prolonged antibiotics, including rifampin, a 50-year-old drug that has been a staple in the global fight against tuberculosis and other bacterial diseases. However, the inability to determine how much rifampin reaches the target site can be disastrous. If not enough rifampin gets to the bacteria infesting implant-assisted bone, it not only limits the drug’s effectiveness, it can lead to development of an antibiotic-resistant strain. Once that happens, even massive doses of medication won’t help. 

In a recent study published Dec. 1, 2021, in the journal Science Translational Medicine, Johns Hopkins Medicine investigators, in collaboration with researchers at three other institutions, circumvented the drug monitoring problem by using positron emission tomography — commonly known as a PET scan — to “see” rifampin’s movement in a living body. 

“We imaged patients with or without orthopaedic implant-associated Staphylococcus aureus infections to show that we could visualize how much rifampin actually penetrates the bone,” says study lead author Oren Gordon, M.D., Ph.D., a pediatric infectious diseases fellow at Johns Hopkins Children’s Center and the Johns Hopkins University School of Medicine. “Then, we used the same procedure on mice bred to mimic Staphylococcus bone infections in humans to define how much rifampin would be needed over time to effectively and safely treat the condition.”

 The patient imaging studies demonstrated that the concentration of rifampin penetrating into bone is only about 14% — or about one-third — as much as previously believed.

 “Taking the results back to the animal model, we determined that giving the mice about three times the currently used rifampin dose substantially increased bone concentration and achieved higher bacterial killing,” says study senior author Sanjay Jain, M.D., professor of pediatrics, and of radiology and radiological sciences at the Johns Hopkins University School of Medicine; and professor of international health at the Johns Hopkins Bloomberg School of Public Health. “We also learned that treating the infections with four weeks of combination antibiotic therapy — including the higher dose of rifampin — was as efficient as the standard six-week treatment using the traditionally prescribed dose.”

“Moreover, the shorter, higher-dose regimen also resulted in fewer antibiotic-resistant strains of Staphylococcus aureus arising in the mice,” adds Gordon.

 “The good news is that the higher doses of rifampin that worked well in the animal model are known to be safe for humans,” says Jain. “However, additional studies are needed to confirm the absolute safety and efficacy of this strategy for the treatment of orthopaedic implant-associated infections, including Staphylococcus aureus and its dangerous variant, methicillin-resistant Staphylococcus aureus [better known by its acronym, MRSA].”

 Along with Gordon and Jain, the members of the research team from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health are Nathan Archer, Robert Dannals, Kimberly Davis, Dustin Dikeman, Bessie Liu, Martin Lodge, Lloyd Miller, Alvaro Ordonez, Steven Rowe, Camilo Ruiz-Bedoya, Babar Shafiq, Paul Sponseller and John Thompson. The researchers participating from other institutions are Jogarao Gobburu, Brooke Langevin and Donald Lee at the University of Maryland School of Pharmacy, Timothy Read at Emory University and Charles Peloquin at the University of Florida College of Pharmacy.

 The study was funded by five National Institutes of Health awards: the Director’s Transformative Research Award R01-EB020539, grant R01-HL131829, grant R01-EB025985, R01-A1153349 and T32A1052071.

 The authors do not have financial or conflict of interest disclosures related to this study.



Journal

Science Translational Medicine

Share12Tweet7Share2ShareShareShare1

Related Posts

Unraveling Odorant Proteins in Kissing Bugs

September 1, 2025

Drumming in Mongolian Gerbils: Context or Arousal?

September 1, 2025

Seasonal Brain Shrinkage in Shrews Caused by Water Loss, Not Cell Death

September 1, 2025

Lower IGF1 Levels in Preeclampsia Affect Trophoblasts

September 1, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

New Predictive Model for Postpartum Hemorrhage in Cesarean Cases

Novel ADC Targets Fucosyl-GM1 in Lung Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.